MHRA revises guidance on periodic safety update reports for UK products
read at raps ↗RegulatoryNeutral
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an update to its pharmacovigilance procedures guidance.
The revision focuses on the preparation and submission of periodic safety update reports (PSURs) for medicines marketed in the United Kingdom.
Companies will need to follow the new advice when compiling safety data, aiming to improve the consistency and timeliness of reporting to the regulator.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Euro Roundup: MHRA updates guidance on submitting safety reports for UK products”
read at raps ↗
comments(0)
5-min edit window · permanent after that